Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 241

Results For "Access"

2516 News Found

Natco Pharma launch Nat-Lenalidomide in Canada
Drug Approval | September 02, 2021

Natco Pharma launch Nat-Lenalidomide in Canada

Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)


Reddy-Lenalidomide launched in Canada
Drug Approval | September 02, 2021

Reddy-Lenalidomide launched in Canada

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian market


Medtech player Healthium acquires CareNow
Packaging | September 02, 2021

Medtech player Healthium acquires CareNow

This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK


Medtronic partners with Stasis to enhance patient monitoring in India
Digitisation | September 02, 2021

Medtronic partners with Stasis to enhance patient monitoring in India

The Stasis connected care monitoring system includes - a bedside monitor that monitors 6 vital signs, a tablet that enables intuitive monitoring, and the Stasis app that allows for remote monitoring across devices


Abbott launch room-temperature carbetocin in India for Postpartum Haemorrhage
News | September 01, 2021

Abbott launch room-temperature carbetocin in India for Postpartum Haemorrhage

PPH is associated with almost 20 per cent of maternal mortality in India


WHO releases compendium of innovative health technologies
Policy | September 01, 2021

WHO releases compendium of innovative health technologies

The Covid-19 pandemic has exposed the divide that exists between rich and developing nations and to address these challenges the World Health Organisation (WHO), has compiled a list of innovative health technologies that aim to bridge the gap


SK Bioscience and GSK start Phase 3 trial of an adjuvanted COVID-19 vaccine candidate
Drug Approval | September 01, 2021

SK Bioscience and GSK start Phase 3 trial of an adjuvanted COVID-19 vaccine candidate

Advance to Phase 3 follows positive interim Phase 1/2 immunogenicity and safety data. The global clinical trial will evaluate vaccine candidate GBP510 against the AZ/Oxford COVID-19 vaccine


Two major hospitals in Gujarat announce tie-up
Healthcare | September 01, 2021

Two major hospitals in Gujarat announce tie-up

Aashka Hospitals has entered into a non-binding agreement for its proposed tie-up with Vaidehi—Backbone hospital, Rajkot


Sher-I-Kashmir Institute of Medical Sciences and Medtronic partner to open Surgical Skills Lab
Digitisation | September 01, 2021

Sher-I-Kashmir Institute of Medical Sciences and Medtronic partner to open Surgical Skills Lab

The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise


Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test
Drug Approval | August 30, 2021

Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test

The Visby Medical sexual health click test is the first instrument-free PCR test for the detection of chlamydia, gonorrhoea and trichomonas, with results available within 30 minutes, during the patient visit